KidneyCAN | Strategic Alliance Partners

home / partners / organizations / kidneycan

KidneyCAN is a nonprofit organization with a mission to accelerate cures for kidney cancer through education, advocacy, and research funding.

Latest from KidneyCAN

Observing changes in the tumor microenvironment before and after a biopsy may elucidate how kidney cancer cells interact with immune cells.

Using Biopsies to Inform Response Characteristics in Kidney Cancer

Eric Jonasch, MD
January 14th 2025

Observing changes in the tumor microenvironment before and after a biopsy may elucidate how kidney cancer cells interact with immune cells.

Various kidney cancer trials have combined agents such as A2a receptor inhibitors with immunotherapy backbones to potentially improve treatment outcomes.

Novel Immunotherapy Trials May Drive Progress in Kidney Cancer Field

Eric Jonasch, MD
January 13th 2025

Various kidney cancer trials have combined agents such as A2a receptor inhibitors with immunotherapy backbones to potentially improve treatment outcomes.

Leveraging novel agents, innovative clinical trial designs, and correlative studies may improve the treatment of patients with kidney cancer.

Kidney Cancer Research Consortium Efforts May Improve Treatment Outcomes

Eric Jonasch, MD
January 11th 2025

Leveraging novel agents, innovative clinical trial designs, and correlative studies may improve the treatment of patients with kidney cancer.

An “avalanche of funding” has propelled the kidney cancer field forward, says Jason Muhitch, PhD.

Kidney Cancer Research Program May Play Pivotal Role in Advancing Care

Elizabeth P. Henske, MD;Jason B. Muhitch, PhD
December 20th 2024

An “avalanche of funding” has propelled the kidney cancer field forward, says Jason Muhitch, PhD.

Advocacy efforts have yielded a dramatic increase in kidney cancer research, according to Elizabeth P. Henske, MD.

Collaboration and Research Funding Advancements in Kidney Cancer Advocacy

Elizabeth P. Henske, MD;Jason B. Muhitch, PhD
December 18th 2024

Advocacy efforts have yielded a dramatic increase in kidney cancer research, according to Elizabeth P. Henske, MD.

Two oncologists discuss the impact of advocacy in kidney cancer research, highlighting collaboration between researchers, advocates, and physicians.

Highlighting Advocacy Impacts on Funding for Kidney Cancer Research

Elizabeth P. Henske, MD;Jason B. Muhitch, PhD
December 16th 2024

Two oncologists discuss the impact of advocacy in kidney cancer research, highlighting collaboration between researchers, advocates, and physicians.